The mirage of AI deregulation
By Alondra Nelson,
Science
| 01. 15. 2026
One of the most interventionist approaches to technology governance in the United States in a generation has cloaked itself in the language of deregulation. In early December 2025, President Donald Trump took to Truth Social to announce a forthcoming “One Rule” executive order on artificial intelligence (AI). Trump warned that US leadership in AI would be “DESTROYED IN ITS INFANCY” by the meddling of “50 States, many of them bad actors, involved in RULES and the APPROVAL PROCESS.” But beneath the bluster was a consequential policy move: the federal preemption of state authority to govern AI, framed as the removal of bureaucratic obstacles from the path for American technological dominance.
This social media post and the executive order that soon followed crystallized the prevailing narrative about the administration’s approach to AI governance: that it is fundamentally deregulatory. This narrative is misleading. Not in its particulars—the Trump administration has indeed rescinded Biden-era AI safety and innovation policies and pressured allies to reduce what it calls “innovation-killing regulations”—but in its core framing. To describe this AI policy as “deregulatory” is...
Related Articles
By Carly Mallenbaum, Axios [cites Emily Galpern] | 03.29.2026
More Americans are turning to surrogacy to build their families, as the practice becomes more common and more publicly discussed.
Why it matters: As surrogacy becomes more visible and accessible, ethical, legal and cultural tensions become harder to ignore...
By Carly Mallenbaum, Axios [cites Surrogacy360] | 03.29.2026
Without a federal law, surrogacy in the U.S. is governed by a patchwork of state regulations/
Why it matters: Confusing, varied local rules can determine everything from whether agreements are legally binding to who is recognized as a parent at...
Cathy Tie seems to be good at starting businesses but not so dedicated to maintaining them. CGS, like many others, first heard of her thanks to Caiwei Chen and Antonio Regalado in MIT Technology Review, May 2025, as the partner (perhaps bride) of the notorious Chinese scientist He Jiankui, described in the headline as “China’s Frankenstein.” He prefers “Chinese Darwin.” She ran his Twitter account for a while, contributing such gems as:
Get in luddite, we’re going gene editing...
By Laura DeFrancesco, Nature Biotechnology | 03.17.2026
The first gene editors designed to fix genetic lesions in mutation-agnostic ways are poised to enter the clinic. Tessera Therapeutics and Alltrna, two Flagship Pioneering-funded companies, are gearing up to test novel genetic medicines in humans. Tessera received regulatory clearance...